Vaxcyte’s Chief Technical Ops Officer, Harpreet S. Dhaliwal, sold 9,743 shares valued at approximately $454,891 in an open-market sale, reducing his direct ownership by 28.9%. The company’s shares dropped 44.2% in the past year, indicating potential challenges ahead. Vaxcyte focuses on developing next-generation vaccines for bacterial diseases, with no approved products in the market.

Read more at Yahoo Finance: Vaxcyte’s Chief Technical Ops Officer Sells Shares